Company DescriptionSabinsa, a manufacturer and ingredient supplier of herbal extracts, cosmeceuticals, probiotics, and specialty fine chemicals used in successful products worldwide, utilizes modern scientific methods to build upon traditional Ayurvedic knowledge to improve human health. In over thirty years, Sabinsa has brought to market more than 120 standardized botanical extracts and privately funded clinical studies in conjunction with prestigious institutions in support of these products. In concert with parent company Sami Labs, the company employs over 1,000 people worldwide in 12 manufacturing, R&D, warehousing and distribution facilities.

Key Market AreasProducts containing Sabinsa’s high-quality, science-based ingredients are found in fine products throughout the world. Sabinsa has marketing offices in the U.S., Australia, Canada, China, Germany, India, Japan, Poland, South Africa, South Korea, and Vietnam, plus agent representation in Far East Asia and South America.

The company’s ingredients are found in dietary supplements and functional foods and beverages, as well as cosmetics and personal care products.

Major Products/Service OfferingsSabinsa has pioneered numerous herbal ingredients in the nutraceuticals market, many of which are the leading branded ingredients in several categories. Sabinsa’s Curcumin C3 Complex® is the most clinically studied turmeric extract in the world. Other popular ingredients include: BioPerine®, LactoSpore®, Promond™, DigeZyme®, Silbinol®, Saberry®, Boswellin®, GarCitrin®, ZeaLutein®, ForsLean®, Bacopin®, Shagandha™, Livinol™, Nigellin™, and many others. Products intended for human consumption are certified Kosher and Halal.

Emphasis on developing and bringing to market products with scientific and clinical substantiation is Sabinsa’s core business philosophy and responsible for fueling the company’s ongoing commercial success. Sabinsa has obtained several IND–approved clinical protocols for its products from the FDA, and offers several ingredients with self-affirmed GRAS status. With more than 120 scientists working full time conducting ongoing research both in India and the U.S., Sabinsa continues to develop and patent beneficial nutrients for the world market. Presently Sabinsa owns over 200 U.S. and International patents and has over 100 pending patent applications worldwide.

In addition to providing science-backed ingredients, Sabinsa’s specialized services include custom product development, technical support and testing lab facilities, assistance in clinical evaluation and protocol implementation. The Utah NSF GMP facility provides contract manufacturing services to develop bulk and packaged finished goods, in various delivery formats such as tablets, bi-layer tablets, and capsules, and intermediary services such as milling, blending, roll compacting, and granulation.

Focus on SustainabilitySami-Sabinsa works with hundreds of small farmers on nearly 40,000 acres who grow significant amounts of high-quality raw materials for processing into branded, usually patented, ingredients. The company’s cultivation program began over a decade ago, after severe weather extremes wiped out the entire harvest for an herb the company needed to supply a popular ingredient. Contracting directly with farmers throughout rural India for the herbs required to make some of their products assures stable supply. Along the way, they have virtually adopted villages, supported schools, and improved rural infrastructure.

Through the years, they have fine-tuned the program, providing seed to the farmers, training them to grow herbs sustainably and cleanly, and guaranteeing a minimum purchase price no matter what Mother Nature throws at them. Farmers are taught techniques to naturally deter insects such as by growing pest-repellent plants among the herbs and given irrigation support when rainfall doesn’t cooperate. When herb prices go up, Sami-Sabinsa pays more for the harvest than the contracted amount.

Reforestation is a logical next step in Sami-Sabinsa’s sustainability commitment. With a view to ex situ conservation of the highly valued but neglected tree species Pterocarpus marsupium (Indian kino tree) two years ago the company initiated and funded a project that planted over 166,600 trees on 250 acres of forest land, which will be maintained over ten years into maturity. The award-winning program was recently expanded to encompass a larger area growing more seedlings.

Contact Us:Sabinsa 20 Lake Drive East Windsor, NJ 08520, USA Phone: 732-777-1111 Fax: in 1988

Key Personnel:Muhammed Majeed, Ph.D., Founder Asha Ramesh, CEO, Sabinsa USA N. Kalyanam, Ph.D., President, R&D Shaheen Majeed, President Worldwide